Candidate for a live vaccine?
Immune dysfunction is a well-known phenomenon in end-stage liver disease (ESLD). The pretransplant period offers a unique window for primary care physicians to optimize the transplant's vaccine protection before antirejection medications are initiated. Live vaccinations are selected cautiously...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
| Series: | Journal of Family Medicine and Primary Care |
| Subjects: | |
| Online Access: | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2017;volume=6;issue=2;spage=445;epage=446;aulast=Abbatemarco |
| _version_ | 1811305659678851072 |
|---|---|
| author | Justin Ralph Abbatemarco Alan Taege |
| author_facet | Justin Ralph Abbatemarco Alan Taege |
| author_sort | Justin Ralph Abbatemarco |
| collection | DOAJ |
| description | Immune dysfunction is a well-known phenomenon in end-stage liver disease (ESLD). The pretransplant period offers a unique window for primary care physicians to optimize the transplant's vaccine protection before antirejection medications are initiated. Live vaccinations are selected cautiously but the varicella-zoster virus (VZV) vaccine, Zostavax, is recommended for pretransplant candidates. This case highlights an ESLD patient who developed disseminated cutaneous VZV within 30 days of vaccination. |
| first_indexed | 2024-04-13T08:29:20Z |
| format | Article |
| id | doaj.art-bea228107b2a495a9d291c175f2303e7 |
| institution | Directory Open Access Journal |
| issn | 2249-4863 |
| language | English |
| last_indexed | 2024-04-13T08:29:20Z |
| publishDate | 2017-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Journal of Family Medicine and Primary Care |
| spelling | doaj.art-bea228107b2a495a9d291c175f2303e72022-12-22T02:54:18ZengWolters Kluwer Medknow PublicationsJournal of Family Medicine and Primary Care2249-48632017-01-016244544610.4103/jfmpc.jfmpc_67_17Candidate for a live vaccine?Justin Ralph AbbatemarcoAlan TaegeImmune dysfunction is a well-known phenomenon in end-stage liver disease (ESLD). The pretransplant period offers a unique window for primary care physicians to optimize the transplant's vaccine protection before antirejection medications are initiated. Live vaccinations are selected cautiously but the varicella-zoster virus (VZV) vaccine, Zostavax, is recommended for pretransplant candidates. This case highlights an ESLD patient who developed disseminated cutaneous VZV within 30 days of vaccination.http://www.jfmpc.com/article.asp?issn=2249-4863;year=2017;volume=6;issue=2;spage=445;epage=446;aulast=AbbatemarcoCirrhosis-associated immune deficiencydisseminated cutaneous varicella zosterend-stage liver diseaseliver transplantationZostavax vaccine |
| spellingShingle | Justin Ralph Abbatemarco Alan Taege Candidate for a live vaccine? Journal of Family Medicine and Primary Care Cirrhosis-associated immune deficiency disseminated cutaneous varicella zoster end-stage liver disease liver transplantation Zostavax vaccine |
| title | Candidate for a live vaccine? |
| title_full | Candidate for a live vaccine? |
| title_fullStr | Candidate for a live vaccine? |
| title_full_unstemmed | Candidate for a live vaccine? |
| title_short | Candidate for a live vaccine? |
| title_sort | candidate for a live vaccine |
| topic | Cirrhosis-associated immune deficiency disseminated cutaneous varicella zoster end-stage liver disease liver transplantation Zostavax vaccine |
| url | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2017;volume=6;issue=2;spage=445;epage=446;aulast=Abbatemarco |
| work_keys_str_mv | AT justinralphabbatemarco candidateforalivevaccine AT alantaege candidateforalivevaccine |